Celebrating the rebellious tangos of Astor Piazzolla through dance and live music, choreographer and international tango ...

Biotech bank balances were again in focus Monday morning, with Tango Therapeutics cutting preclinical work to stretch its cash runway and Avalo Therapeutics outlining options for preserving its money.

Tango Therapeutics (NASDAQ:TNGX) added ~15% in the premarket on Thursday after the oncology-focused biotech announced an early-stage trial readout for its anticancer agent vopimetostat (TNG462) in ...

Tango Therapeutics, Inc. remains a high-risk, high-reward biotech, focused on PRMT5 inhibitors for MTAP-deleted cancers—a large, underserved market opportunity. Disappointing clinical data last ...

PRYME Audio Accessories has aligned with Tango Tango to provide seamless, hands-free push-to-talk over cellular solutions for ...